P1446: PHASE I STUDY DATA UPDATE OF PHE885, A FULLY HUMAN BCMA-DIRECTED CAR-T CELL THERAPY MANUFACTURED USING THE T-CHARGETM PLATFORM FOR PATIENTS WITH RELAPSED/REFRACTORY (R/R) MULTIPLE MYELOMA (MM)

Detalles Bibliográficos
Autores principales: Sperling, A. S., Nikiforow, S., Derman, B., Nadeem, O., Mo, C., Laubach, J., Anderson, K., Alonso, A., Im, S.-Y., Ikwgawa, S., Prabhala, R., Hernandez Rodriduez, D., Daley, H., Shaw, K. L., Arihara, Y., Ansari, S., Quinn, D. S., Pearson, D., Hack, A., Treanor, L., Bu, D., Mataraza, J., Rispoli, L., Credi, M., Ritz, J., Jakubowiak, A., De Vita, S., Munshi, N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2022
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430604/
http://dx.doi.org/10.1097/01.HS9.0000848640.53562.8f
_version_ 1784779817014525952
author Sperling, A. S.
Nikiforow, S.
Derman, B.
Nadeem, O.
Mo, C.
Laubach, J.
Anderson, K.
Alonso, A.
Im, S.-Y.
Ikwgawa, S.
Prabhala, R.
Hernandez Rodriduez, D.
Daley, H.
Shaw, K. L.
Arihara, Y.
Ansari, S.
Quinn, D. S.
Pearson, D.
Hack, A.
Treanor, L.
Bu, D.
Mataraza, J.
Rispoli, L.
Credi, M.
Ritz, J.
Jakubowiak, A.
De Vita, S.
Munshi, N.
author_facet Sperling, A. S.
Nikiforow, S.
Derman, B.
Nadeem, O.
Mo, C.
Laubach, J.
Anderson, K.
Alonso, A.
Im, S.-Y.
Ikwgawa, S.
Prabhala, R.
Hernandez Rodriduez, D.
Daley, H.
Shaw, K. L.
Arihara, Y.
Ansari, S.
Quinn, D. S.
Pearson, D.
Hack, A.
Treanor, L.
Bu, D.
Mataraza, J.
Rispoli, L.
Credi, M.
Ritz, J.
Jakubowiak, A.
De Vita, S.
Munshi, N.
author_sort Sperling, A. S.
collection PubMed
description
format Online
Article
Text
id pubmed-9430604
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-94306042022-08-31 P1446: PHASE I STUDY DATA UPDATE OF PHE885, A FULLY HUMAN BCMA-DIRECTED CAR-T CELL THERAPY MANUFACTURED USING THE T-CHARGETM PLATFORM FOR PATIENTS WITH RELAPSED/REFRACTORY (R/R) MULTIPLE MYELOMA (MM) Sperling, A. S. Nikiforow, S. Derman, B. Nadeem, O. Mo, C. Laubach, J. Anderson, K. Alonso, A. Im, S.-Y. Ikwgawa, S. Prabhala, R. Hernandez Rodriduez, D. Daley, H. Shaw, K. L. Arihara, Y. Ansari, S. Quinn, D. S. Pearson, D. Hack, A. Treanor, L. Bu, D. Mataraza, J. Rispoli, L. Credi, M. Ritz, J. Jakubowiak, A. De Vita, S. Munshi, N. Hemasphere Posters Lippincott Williams & Wilkins 2022-06-23 /pmc/articles/PMC9430604/ http://dx.doi.org/10.1097/01.HS9.0000848640.53562.8f Text en Copyright © 2022 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Sperling, A. S.
Nikiforow, S.
Derman, B.
Nadeem, O.
Mo, C.
Laubach, J.
Anderson, K.
Alonso, A.
Im, S.-Y.
Ikwgawa, S.
Prabhala, R.
Hernandez Rodriduez, D.
Daley, H.
Shaw, K. L.
Arihara, Y.
Ansari, S.
Quinn, D. S.
Pearson, D.
Hack, A.
Treanor, L.
Bu, D.
Mataraza, J.
Rispoli, L.
Credi, M.
Ritz, J.
Jakubowiak, A.
De Vita, S.
Munshi, N.
P1446: PHASE I STUDY DATA UPDATE OF PHE885, A FULLY HUMAN BCMA-DIRECTED CAR-T CELL THERAPY MANUFACTURED USING THE T-CHARGETM PLATFORM FOR PATIENTS WITH RELAPSED/REFRACTORY (R/R) MULTIPLE MYELOMA (MM)
title P1446: PHASE I STUDY DATA UPDATE OF PHE885, A FULLY HUMAN BCMA-DIRECTED CAR-T CELL THERAPY MANUFACTURED USING THE T-CHARGETM PLATFORM FOR PATIENTS WITH RELAPSED/REFRACTORY (R/R) MULTIPLE MYELOMA (MM)
title_full P1446: PHASE I STUDY DATA UPDATE OF PHE885, A FULLY HUMAN BCMA-DIRECTED CAR-T CELL THERAPY MANUFACTURED USING THE T-CHARGETM PLATFORM FOR PATIENTS WITH RELAPSED/REFRACTORY (R/R) MULTIPLE MYELOMA (MM)
title_fullStr P1446: PHASE I STUDY DATA UPDATE OF PHE885, A FULLY HUMAN BCMA-DIRECTED CAR-T CELL THERAPY MANUFACTURED USING THE T-CHARGETM PLATFORM FOR PATIENTS WITH RELAPSED/REFRACTORY (R/R) MULTIPLE MYELOMA (MM)
title_full_unstemmed P1446: PHASE I STUDY DATA UPDATE OF PHE885, A FULLY HUMAN BCMA-DIRECTED CAR-T CELL THERAPY MANUFACTURED USING THE T-CHARGETM PLATFORM FOR PATIENTS WITH RELAPSED/REFRACTORY (R/R) MULTIPLE MYELOMA (MM)
title_short P1446: PHASE I STUDY DATA UPDATE OF PHE885, A FULLY HUMAN BCMA-DIRECTED CAR-T CELL THERAPY MANUFACTURED USING THE T-CHARGETM PLATFORM FOR PATIENTS WITH RELAPSED/REFRACTORY (R/R) MULTIPLE MYELOMA (MM)
title_sort p1446: phase i study data update of phe885, a fully human bcma-directed car-t cell therapy manufactured using the t-chargetm platform for patients with relapsed/refractory (r/r) multiple myeloma (mm)
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9430604/
http://dx.doi.org/10.1097/01.HS9.0000848640.53562.8f
work_keys_str_mv AT sperlingas p1446phaseistudydataupdateofphe885afullyhumanbcmadirectedcartcelltherapymanufacturedusingthetchargetmplatformforpatientswithrelapsedrefractoryrrmultiplemyelomamm
AT nikiforows p1446phaseistudydataupdateofphe885afullyhumanbcmadirectedcartcelltherapymanufacturedusingthetchargetmplatformforpatientswithrelapsedrefractoryrrmultiplemyelomamm
AT dermanb p1446phaseistudydataupdateofphe885afullyhumanbcmadirectedcartcelltherapymanufacturedusingthetchargetmplatformforpatientswithrelapsedrefractoryrrmultiplemyelomamm
AT nadeemo p1446phaseistudydataupdateofphe885afullyhumanbcmadirectedcartcelltherapymanufacturedusingthetchargetmplatformforpatientswithrelapsedrefractoryrrmultiplemyelomamm
AT moc p1446phaseistudydataupdateofphe885afullyhumanbcmadirectedcartcelltherapymanufacturedusingthetchargetmplatformforpatientswithrelapsedrefractoryrrmultiplemyelomamm
AT laubachj p1446phaseistudydataupdateofphe885afullyhumanbcmadirectedcartcelltherapymanufacturedusingthetchargetmplatformforpatientswithrelapsedrefractoryrrmultiplemyelomamm
AT andersonk p1446phaseistudydataupdateofphe885afullyhumanbcmadirectedcartcelltherapymanufacturedusingthetchargetmplatformforpatientswithrelapsedrefractoryrrmultiplemyelomamm
AT alonsoa p1446phaseistudydataupdateofphe885afullyhumanbcmadirectedcartcelltherapymanufacturedusingthetchargetmplatformforpatientswithrelapsedrefractoryrrmultiplemyelomamm
AT imsy p1446phaseistudydataupdateofphe885afullyhumanbcmadirectedcartcelltherapymanufacturedusingthetchargetmplatformforpatientswithrelapsedrefractoryrrmultiplemyelomamm
AT ikwgawas p1446phaseistudydataupdateofphe885afullyhumanbcmadirectedcartcelltherapymanufacturedusingthetchargetmplatformforpatientswithrelapsedrefractoryrrmultiplemyelomamm
AT prabhalar p1446phaseistudydataupdateofphe885afullyhumanbcmadirectedcartcelltherapymanufacturedusingthetchargetmplatformforpatientswithrelapsedrefractoryrrmultiplemyelomamm
AT hernandezrodriduezd p1446phaseistudydataupdateofphe885afullyhumanbcmadirectedcartcelltherapymanufacturedusingthetchargetmplatformforpatientswithrelapsedrefractoryrrmultiplemyelomamm
AT daleyh p1446phaseistudydataupdateofphe885afullyhumanbcmadirectedcartcelltherapymanufacturedusingthetchargetmplatformforpatientswithrelapsedrefractoryrrmultiplemyelomamm
AT shawkl p1446phaseistudydataupdateofphe885afullyhumanbcmadirectedcartcelltherapymanufacturedusingthetchargetmplatformforpatientswithrelapsedrefractoryrrmultiplemyelomamm
AT ariharay p1446phaseistudydataupdateofphe885afullyhumanbcmadirectedcartcelltherapymanufacturedusingthetchargetmplatformforpatientswithrelapsedrefractoryrrmultiplemyelomamm
AT ansaris p1446phaseistudydataupdateofphe885afullyhumanbcmadirectedcartcelltherapymanufacturedusingthetchargetmplatformforpatientswithrelapsedrefractoryrrmultiplemyelomamm
AT quinnds p1446phaseistudydataupdateofphe885afullyhumanbcmadirectedcartcelltherapymanufacturedusingthetchargetmplatformforpatientswithrelapsedrefractoryrrmultiplemyelomamm
AT pearsond p1446phaseistudydataupdateofphe885afullyhumanbcmadirectedcartcelltherapymanufacturedusingthetchargetmplatformforpatientswithrelapsedrefractoryrrmultiplemyelomamm
AT hacka p1446phaseistudydataupdateofphe885afullyhumanbcmadirectedcartcelltherapymanufacturedusingthetchargetmplatformforpatientswithrelapsedrefractoryrrmultiplemyelomamm
AT treanorl p1446phaseistudydataupdateofphe885afullyhumanbcmadirectedcartcelltherapymanufacturedusingthetchargetmplatformforpatientswithrelapsedrefractoryrrmultiplemyelomamm
AT bud p1446phaseistudydataupdateofphe885afullyhumanbcmadirectedcartcelltherapymanufacturedusingthetchargetmplatformforpatientswithrelapsedrefractoryrrmultiplemyelomamm
AT matarazaj p1446phaseistudydataupdateofphe885afullyhumanbcmadirectedcartcelltherapymanufacturedusingthetchargetmplatformforpatientswithrelapsedrefractoryrrmultiplemyelomamm
AT rispolil p1446phaseistudydataupdateofphe885afullyhumanbcmadirectedcartcelltherapymanufacturedusingthetchargetmplatformforpatientswithrelapsedrefractoryrrmultiplemyelomamm
AT credim p1446phaseistudydataupdateofphe885afullyhumanbcmadirectedcartcelltherapymanufacturedusingthetchargetmplatformforpatientswithrelapsedrefractoryrrmultiplemyelomamm
AT ritzj p1446phaseistudydataupdateofphe885afullyhumanbcmadirectedcartcelltherapymanufacturedusingthetchargetmplatformforpatientswithrelapsedrefractoryrrmultiplemyelomamm
AT jakubowiaka p1446phaseistudydataupdateofphe885afullyhumanbcmadirectedcartcelltherapymanufacturedusingthetchargetmplatformforpatientswithrelapsedrefractoryrrmultiplemyelomamm
AT devitas p1446phaseistudydataupdateofphe885afullyhumanbcmadirectedcartcelltherapymanufacturedusingthetchargetmplatformforpatientswithrelapsedrefractoryrrmultiplemyelomamm
AT munshin p1446phaseistudydataupdateofphe885afullyhumanbcmadirectedcartcelltherapymanufacturedusingthetchargetmplatformforpatientswithrelapsedrefractoryrrmultiplemyelomamm

Ejemplares similares